Evotec SE (EVO) Earnings Date & Reports

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVO is expected to report earnings to fall 145.12% to 18 cents per share on August 13

Q2'26

Est.

$0.18

Q1'26

Missed

by $0.23

Q4'25

Beat

by $0.02

Q3'25

Beat

by $0.03

Q2'25

Missed

by $0.08

The last earnings report on May 06 showed earnings per share of -40 cents, missing the estimate of -17 cents. With 19.64K shares outstanding, the current market capitalization sits at 950.65M.

View a ticker or compare two or three

Compare

EVO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for EVO